Cardiac Monitoring Devices Market Report Scope & Overview:

The Cardiac Monitoring Devices Market was valued at USD 20.19 Billion in 2025 and is expected to reach USD 35.89 Billion by 2035, growing at a CAGR of 5.92% from 2026-2035.

Cardiac monitoring devices track the heart's electrical activity and rhythm, spanning from a simple resting ECG machine used during a routine office visit through implantable monitors inserted beneath the skin that continuously track heart rhythm for years without requiring a wire or external sensor. These devices give physicians the diagnostic evidence needed to catch arrhythmias, including atrial fibrillation, that may occur unpredictably for a brief in-office examination ever to capture. Growth is supported by the increasing geriatric population and rising prevalence of cardiovascular diseases worldwide, growing adoption of wireless and wearable monitoring technology, and continued integration of artificial intelligence that increasingly helps clinicians separate genuine arrhythmias from the false alerts that have long burdened device clinic staff reviewing enormous volumes of monitoring data.

In February 2026, the FDA approved Abbott's CardioMEMS HERO device, a next-generation pulmonary artery pressure sensor designed for heart failure monitoring, redesigned for improved portability and ease of use relative to the original CardioMEMS reader, reinforcing Abbott's position in the high-value implantable cardiac monitoring segment as competitive intensity around battery life and miniaturisation continues to escalate between the market's leading manufacturers.

Cardiac Monitoring Devices Market Trends

• Rising adoption of AI-enabled algorithms reducing false arrhythmia alerts from implantable cardiac monitors.
• Growing extension of continuous cardiac monitor battery life, with some implantable devices now lasting six years.
• Expanding consolidation as cardiac monitoring companies acquire complementary multi-vitals monitoring platforms.
• Increasing shift of cardiac monitoring toward home care settings supported by remote patient monitoring programs.
• Rising adoption of long-term continuous patch-based ECG monitors capturing extended, uninterrupted rhythm data.
• Growing integration of pulsed field ablation and cardiac monitoring technology within unified device ecosystems.

U.S. Cardiac Monitoring Devices Market Overview

The U.S. Cardiac Monitoring Devices Market was valued at USD 6.15 Billion in 2025 and is expected to reach USD 10.45 Billion by 2035, growing at a CAGR of 5.45% from 2026-2035.

The U.S. Cardiac Monitoring Devices Market benefits from a substantial and ageing population with rising cardiovascular disease prevalence, broad insurance and Medicare reimbursement coverage for both diagnostic and long-term monitoring devices, and the presence of leading cardiac device manufacturers headquartered in the country that continue to compete intensely on battery life, AI integration, and monitoring duration. Leading manufacturers continue to pursue strategic acquisitions that broaden their monitoring platforms beyond single-purpose cardiac devices toward comprehensive, multi-vitals monitoring ecosystems spanning ambulatory, inpatient, and hospital-to-home care settings. Continued expansion of remote patient monitoring reimbursement continues to support the shift of cardiac monitoring from hospital settings toward the home. Continued innovation in AI-powered arrhythmia detection is expected to sustain strong demand growth throughout the forecast period.

In June 2025, iRhythm Holdings announced an agreement to acquire VitalConnect for approximately USD 287.5 million, a transaction the company expects will immediately expand its cardiac monitoring platform across ambulatory, inpatient, and hospital-to-home care settings, adding FDA-cleared multi-vitals monitoring capabilities to iRhythm's existing ambulatory ECG monitoring business and advancing its evolution into a broader cardiac monitoring and intelligence platform.

Cardiac Monitoring Devices Market Segment Analysis

• By Product Type, the ECG Devices segment dominated the market with a 33.65% share in 2025, while the Mobile Cardiac Telemetry segment is the fastest growing with a CAGR of 8.75% during 2026-2035.
• By Monitoring Type, the Continuous Monitoring segment dominated the market with a 44.60% share in 2025, while the Continuous Monitoring segment is the fastest growing with a CAGR of 8.15% during 2026-2035.
• By Technology, the Wireless Monitoring Systems segment dominated the market with a 55.85% share in 2025, while the AI-Enabled Platforms segment is the fastest growing with a CAGR of 9.45% during 2026-2035.
• By Application, the Arrhythmia Detection & Monitoring segment dominated the market with an estimated 32.00% share in 2025, while the Heart Failure Monitoring segment is the fastest growing with an estimated CAGR of 7.25% during 2026-2035.
• By End User, the Hospitals and Clinics segment dominated the market with a 49.60% share in 2025, while the Home Care Settings segment is the fastest growing with a CAGR of 8.65% during 2026-2035.

By Product Type, ECG Devices Dominates the Market and Mobile Cardiac Telemetry Grows Fastest

ECG devices dominated the market in 2025. Electrocardiogram machines continue to represent the most widely used and universally available cardiac diagnostic tool, performed routinely in nearly every clinical encounter where heart health is a concern, sustaining ECG devices' position as the largest product type category across the broader cardiac monitoring devices market.

Mobile cardiac telemetry is projected to be the fastest-growing product type over the forecast period, as rising demand for continuous, real-time rhythm monitoring beyond what short-duration Holter monitors can capture continues to expand clinical adoption. Continued extension of wearable patch monitor capability continues to drive above-market growth for this product type.

By Monitoring Type, Continuous Monitoring Dominates the Market and Continuous Monitoring Grows Fastest

Continuous monitoring dominated the market in 2025. This monitoring approach continues to offer physicians the uninterrupted rhythm data needed to catch intermittent arrhythmias that brief, intermittent snapshots might miss entirely, sustaining continuous monitoring's position as the largest monitoring type category across the broader market.

Continuous monitoring is also expected to grow fastest over the forecast period, as rising demand for longer-duration, uninterrupted rhythm capture continues to reinforce this monitoring type's already dominant position even further relative to intermittent approaches that increasingly struggle to match continuous monitoring's diagnostic yield for elusive arrhythmias.

By Technology, Wireless Monitoring Systems Dominates the Market and AI-Enabled Platforms Grows Fastest

Wireless monitoring systems dominated the market in 2025. The convenience and patient comfort wireless connectivity offers relative to wired alternatives continues to make it the default technology choice across modern cardiac monitoring devices, sustaining wireless systems' position as the largest technology category across the broader market.

AI-enabled platforms are projected to be the fastest-growing technology over the forecast period, as continued advancement in algorithmic arrhythmia detection continues to reduce the false alert burden that has long challenged device clinic staff. Rising clinical confidence in AI-assisted interpretation continues to drive above-market growth for this technology.

By Application, Arrhythmia Detection & Monitoring Dominates the Market and Heart Failure Monitoring Grows Fastest

The Arrhythmia Detection & Monitoring segment is estimated to have accounted for larger share of the Cardiac Monitoring Devices Market in 2025, making it the leading application segment. Growing prevalence of atrial fibrillation and other cardiac rhythm disorders is driving demand for continuous and accurate monitoring solutions. Hospitals and clinics increasingly use ECG systems, Holter monitors, and wearable cardiac devices for early detection and long-term patient monitoring. Rising awareness of cardiovascular health, aging populations, and technological advancements in remote monitoring are further supporting adoption of arrhythmia detection solutions across healthcare settings.

The Heart Failure Monitoring section is forecasted to become the fastest-growing application between 2026 and 2035. The rising incidence of heart failure among older people is leading to increased use of continuous monitoring technology for this purpose. The increasing adoption of remote and wearable devices to monitor patients beyond hospitals is contributing to the growth of this segment. Advancements in connected cardiac monitoring, remote patient monitoring platforms, and wearable sensors are improving the ability to identify changes in patients’ conditions. Growing emphasis on preventive cardiac care is expected to further accelerate segment growth.

By End User, Hospitals and Clinics Dominates the Market and Home Care Settings Grows Fastest

Hospitals and clinics dominated the market in 2025. The continuous, high-acuity cardiac monitoring these facilities perform across emergency, inpatient, and outpatient settings continues to anchor hospitals and clinics as the largest end-user category across the broader cardiac monitoring devices market by a considerable margin.

Home care settings are projected to be the fastest-growing end-user category over the forecast period, as expanding remote patient monitoring reimbursement and rising patient preference for monitoring outside traditional clinical settings continue to shift a growing share of cardiac monitoring activity toward the home.

Regional Analysis

North America Cardiac Monitoring Devices Market Insights

North America dominated the market with a 36.85% share in 2025. A substantial and ageing population, broad insurance and Medicare reimbursement coverage, and the concentration of leading cardiac device manufacturers headquartered within the region continue to anchor this leadership position across every major product type and technology category.

Canada contributes meaningful incremental regional demand through its own publicly funded healthcare system. Continued AI-enabled device innovation and strategic acquisition activity among leading manufacturers is expected to keep North America in the lead through the forecast period, even as its growth trails faster-scaling Asia Pacific markets.

Asia Pacific Cardiac Monitoring Devices Market Insights

Asia Pacific is projected to be the fastest-growing region over the forecast period, registering a CAGR of approximately 8.35% during the forecast period from 2026-2035. Rapidly expanding hospital infrastructure, rising cardiovascular disease prevalence, and growing government healthcare investment across the region's major economies continue to accelerate regional adoption of cardiac monitoring devices.

China anchors regional demand through its expanding hospital network and growing domestic cardiac device manufacturing base. India contributes substantial regional growth as cardiovascular disease diagnosis rates rise, while Japan and South Korea add mature, technology-oriented demand through established cardiac monitoring infrastructure.

Europe Cardiac Monitoring Devices Market Insights

Europe holds a significant share of the global market, anchored by Germany's substantial healthcare sector and the region's well-developed public health insurance framework, which continues to sustain steady demand across every major cardiac monitoring device category.

The United Kingdom, France, and Italy add consistent regional demand as national health systems continue extending cardiac monitoring access. Continued regional investment in remote patient monitoring infrastructure is expected to sustain steady growth across the broader European market through the forecast period.

MEA and Latin America Cardiac Monitoring Devices Market Insights

The Middle East and Africa region is supported by growing healthcare infrastructure investment across the United Arab Emirates and Saudi Arabia, where regional governments continue expanding specialist cardiology capacity as part of broader healthcare modernisation strategies.

Latin America is anchored by Brazil, where a growing domestic healthcare sector sustains steady demand for cardiac monitoring devices. Mexico contributes further incremental growth as regional healthcare access and cardiovascular disease diagnosis continue to expand gradually across the broader region.

Market Dynamics

Growth Drivers: Ageing Population and Wireless Technology Adoption

The increasing geriatric population and rising prevalence of cardiovascular diseases stand as the primary growth driver, as rising cardiac disease incidence directly expands the diagnosed patient population requiring regular rhythm monitoring across hospital, outpatient, and home settings worldwide.

Growing adoption of wireless and wearable monitoring technology represents a second major driver, as continued extension of battery life and monitoring duration keeps expanding how comfortably patients can be monitored over longer periods. Continued AI integration further reinforces sustained demand by reducing false alert burden for clinical staff.

Restraints: High Device Cost and Reimbursement Variability

High cost of advanced implantable and continuous monitoring devices remains a genuine restraint, as the price differential relative to simpler diagnostic alternatives continues to limit broader adoption among patients without comprehensive insurance coverage, particularly for the longest-duration monitoring devices.

Reimbursement variability across healthcare systems presents a further restraint, as coverage policies for remote and continuous cardiac monitoring continue to differ considerably between countries, creating genuine access inconsistency for patients who could otherwise benefit from extended monitoring capability.

Opportunities: AI-Powered Arrhythmia Detection and Home Monitoring Expansion

Continued development of AI-powered arrhythmia detection represents a substantial opportunity, as manufacturers that can deliver genuinely reliable, false-alert-reducing algorithms stand to capture demand from device clinics burdened by the sheer volume of monitoring data continuous devices generate.

Continued expansion of home-based cardiac monitoring offers a further avenue for growth, as manufacturers that can deliver reliable remote monitoring capability are positioned to capture demand from an ageing patient population increasingly preferring to be monitored outside traditional hospital and clinic settings.

Recent Developments:

• 2026: Medtronic plc received FDA clearance and CE Mark for Affera Prism-2 Mapping Software, expanding advanced cardiac electrical mapping capabilities for arrhythmia procedures and supporting more precise cardiac monitoring workflows.
• 2026: Koninklijke Philips N.V. expanded its connected patient-monitoring ecosystem through collaborations with six wearable technology companies, integrating ECG and multi-parameter monitoring data for hospital-to-home care.
• 2026: GE HealthCare Technologies Inc. highlighted its newly FDA-cleared Photonova Spectra and ReadyFix-enabled MAC VU360 ECG workstations, strengthening AI-enabled cardiology diagnostics and remote device-management capabilities.

Cardiac Monitoring Devices Market Key Players are:

• Medtronic plc
• Abbott Laboratories
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Boston Scientific Corporation
• Biotronik SE & Co. KG
• iRhythm Technologies, Inc.
• Baxter International Inc. (Hillrom)
• Nihon Kohden Corporation
• Spacelabs Healthcare (OSI Systems)
• Schiller AG
• VitalConnect, Inc.
• CardioComm Solutions, Inc.
• AliveCor, Inc.
• Preventice Solutions (Boston Scientific)
• InfoBionic, Inc.
• Biobeat Technologies Ltd.
• Welch Allyn (Hillrom)
• PaceMate
• Implicity

Cardiac Monitoring Devices Market Report Scope: